Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Follow-Up Questions
Cosmos Health Inc (COSM)의 PER은 얼마입니까?
Cosmos Health Inc의 PER은 N/A입니다
Cosmos Health Inc의 CEO는 누구입니까?
Mr. Grigorios Siokas은 2016부터 회사에 합류한 Cosmos Health Inc의 Chairman of the Board입니다.
COSM 주식의 가격 성능은 어떻습니까?
COSM의 현재 가격은 0.945이며, 전 거래일에 increased 1.4% 하였습니다.
Cosmos Health Inc의 주요 사업 주제나 업종은 무엇입니까?
Cosmos Health Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Cosmos Health Inc의 시가총액은 얼마입니까?
Cosmos Health Inc의 현재 시가총액은 $28.5입니다
Cosmos Health Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Cosmos Health Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다